Sales1 Mar 2022 20:07
A small listed company’s SP only rises on the belief in future sales, or sizeable margins on current sales. CBX is failing on both. Four products in this line does not warrant a valuation based on SP of £22M. Do we believe that they will deliver an expanded range without consolidated income from the current? If you do, leave your money in or even gamble more. Or part with your money when they will inevitably ask for more as I doubt current sales will deliver sufficiently to support any expansion of the product line. Personally, I’ve lost a few ££s. I do, however, think that the SP will rise on the forthcoming marketing. But I also don’t think that it will be sustained, so I’ll bail when I think I’ve limited losses enough. Just my opinion.